US Broker Ratings

Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: A 36.45% Potential Upside Captivates Investors

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) has been catching the eye of investors, particularly with the enticing potential upside of 36.45%, as indicated by analysts’ average target price. This biopharmaceutical company,..

Denali Therapeutics Inc. (DNLI) Stock Analysis: A Biotech Powerhouse with 101% Upside Potential

Denali Therapeutics Inc. (NASDAQ: DNLI) is making waves in the biotechnology sector with its ambitious pipeline targeting some of the most challenging neurodegenerative and lysosomal storage diseases. With a market..

Zai Lab Limited (ZLAB): Investor Outlook on a Biotech Powerhouse with a Promising 171% Upside

Investors keeping an eye on the biotechnology sector should not overlook Zai Lab Limited (NASDAQ: ZLAB), a prominent player in the healthcare industry. With a market capitalization of $2 billion,..

Organon & Co. (OGN) Stock Analysis: Exploring the 25.77% Potential Upside for Investors

Investors on the lookout for opportunities in the healthcare sector may find Organon & Co. (NYSE: OGN) an intriguing prospect. With a market capitalization of $1.93 billion, this company is..

Crinetics Pharmaceuticals (CRNX) Stock Analysis: A Deep Dive into 71% Upside Potential

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) is capturing investor attention with its significant upside potential, evident in the latest analyst ratings that suggest a possible 71.08% increase from its current stock..

Apellis Pharmaceuticals, Inc. (APLS) Stock Analysis: Navigating a 40.73% Potential Upside in the Biotech Space

Apellis Pharmaceuticals, Inc. (APLS), a prominent player in the biotechnology industry, continues to capture investor attention with its strategic focus on novel therapeutic compounds. Based in Waltham, Massachusetts, Apellis is..

Perrigo Company plc (PRGO) Stock Analysis: Exploring a Potential 48.20% Upside with a High Dividend Yield

Perrigo Company plc (NASDAQ: PRGO) stands as a significant player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. Headquartered in Dublin, Ireland, Perrigo’s extensive portfolio..

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Navigating Challenges with a Promising Dividend Yield

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a prominent player in the healthcare sector, specializing in medical instruments and supplies, is currently attracting attention with its compelling dividend yield amidst a challenging..

Surgery Partners, Inc. (SGRY) Stock Analysis: Exploring a 65.94% Upside Potential Amid Sector Growth

Surgery Partners, Inc. (NASDAQ: SGRY) has emerged as an intriguing proposition for investors eyeing the healthcare sector. With its strategic focus on surgical facilities and ancillary services, the company has..

Viking Therapeutics, Inc. (VKTX): Biotech Stock with a 190% Upside Potential – An Investor’s Insight

Viking Therapeutics, Inc. (NASDAQ: VKTX) has been capturing the attention of investors in the biotech sector, thanks to its ambitious drug development pipeline and the potential for significant stock appreciation...

LivaNova PLC (LIVN) Stock Analysis: Exploring a Potential 11.71% Upside in Medical Devices

As the healthcare sector continues to play a pivotal role in global economies, LivaNova PLC (NASDAQ: LIVN) stands out as a noteworthy player in the medical devices industry. Headquartered in..

Envista Holdings Corporation (NVST) Stock Analysis: Navigating Opportunities in the Dental Industry

Envista Holdings Corporation (NYSE: NVST), a prominent player in the healthcare sector, is capturing investor interest with its focus on dental products. Operating primarily within the medical instruments and supplies..

Scholar Rock Holding Corporation (SRRK) Stock Analysis: Biotechnology Innovator with a Promising 12% Upside

In the dynamic and often volatile world of biotechnology, Scholar Rock Holding Corporation (NASDAQ: SRRK) stands out for its innovative approach to tackling serious diseases. With a market capitalization of..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: Navigating Growth with a 43.5% Revenue Surge

Alignment Healthcare, Inc. (NASDAQ: ALHC) is making waves in the healthcare sector with its innovative approach to senior care through Medicare Advantage plans. With a market capitalization of $4.2 billion,..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Navigating the Biotech Frontier with a 6.64% Potential Upside

In the ever-evolving landscape of biotechnology, PTC Therapeutics, Inc. (NASDAQ: PTCT) stands out as a significant player. With its focus on rare disorders, the company is making strides in developing..

Haemonetics Corporation (HAE) Stock Analysis: Insights into a Promising Medical Device Leader with a 9.85% Upside

Haemonetics Corporation (NYSE: HAE) stands as a prominent player in the healthcare sector, specifically in the medical devices industry. With a market capitalization of $3.96 billion, the company has solidified..

Sotera Health Company (SHC) Stock Analysis: Healthcare Powerhouse with a 3.43% Potential Upside

Sotera Health Company (NASDAQ: SHC), a prominent player in the healthcare sector, specializing in diagnostics and research, is catching the attention of investors with its robust service offerings and promising..

Rhythm Pharmaceuticals, Inc. (RYTM): Analyst Consensus and Growth Potential Amidst a 32% Upside

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) stands out in the biotechnology sector with its focus on rare neuroendocrine diseases. Known for its flagship product, IMCIVREE, designed to address genetic obesity disorders,..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: A Biotech Pioneer with a Mixed Valuation Outlook

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) stands as a significant player in the biotechnology sector, focusing on pioneering treatments for rare genetic diseases. Headquartered in Cambridge, Massachusetts, Sarepta has carved a..

Inspire Medical Systems, Inc. (INSP): Investor Outlook with a 51.73% Potential Upside

Inspire Medical Systems, Inc. (NASDAQ: INSP), a trailblazer in the healthcare sector, particularly within the medical devices industry, has garnered significant attention for its innovative approach to treating obstructive sleep..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds